Cervical cancer: open trials in Spain

23 open trials have a site in Spain. Registry data; only the trial team decides who can take part.

NCT07216703
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario Reina Sofia, Córdoba · Institut Català d'Oncologia, Girona · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario La Paz, Madrid · Hospital Universitario Ramón y Cajal, Madrid · Hospital Clinico Universitario de Valencia, Valencia
Registry updated 2026-11-06
NCT06400472
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Trial Treatment · Phase 1 · Eli Lilly and Company
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario 12 de Octubre, Madrid · Hospital Clinico Universitario de Valencia, Valencia
Registry updated 2026-11-04
NCT06465069
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Trial Treatment · Phase 1 · Eli Lilly and Company
Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital Universitario HM Sanchinarro, Madrid · Hospital Universitario 12 de Octubre, Madrid · University Hospital Virgen Del Rocio S.L., Sevilla
Registry updated 2026-11-04
NCT06760819
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Trial Treatment · Phase 2 · Bayer
Instituto Oncologico Dr. Rosell S.L. | Oncologia, Barcelona · Hospital Universitari Vall D Hebron | Oncologia Medica, Barcelona · Institut Catala D'oncologia | Hospitalet | Oncologia, L'Hospitalet de Llobregat · Clinica Universidad De Navarra | Madrid | Oncologia, Madrid · Hospital Universitario Fundacion Jimenez Diaz | Oncologia Medica, Madrid
Registry updated 2026-11-04
NCT06953089
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Trial Treatment · Phase 2 · DualityBio Inc.
Complexo Hospitalario Universitario A Coruña, A Coruña · Hospital HM Nou Delfos, Barcelona · Institut Català d'Oncologia, Girona · Institut Catala D'oncologia, L'Hospitalet de Llobregat · Fundacion Rioja Salud, Logrono
Registry updated 2026-10-29
NCT07109726
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Trial Treatment · Phase 1/2 · Terremoto Biosciences Inc.
START Research Center at Hospital HM Nou Delfos, Barcelona · Hospital Universitario General de Catalunya, Barcelona · START Madrid Fundacion Jimenez Diaz, Madrid · Md Anderson Cancer Center Madrid-Hospiten, Madrid
Registry updated 2026-10-28
NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 2 · Daiichi Sankyo
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Clinic de Barcelona, Barcelona · Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitario 12 de Octubre, Madrid · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario Ramón y Cajal, Madrid · HOSPITAL REGIONAL UNIVERSITARIO de MALAGA AVDA., Málaga · Hospital Universitario Virgen Macarena, Seville · Hospital Clinico Universitario de Valencia, Valencia
Registry updated 2026-10-26
NCT06330064
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Trial Treatment · Phase 1/2 · Daiichi Sankyo
Hospital Universitari Vall d'Hebron, Barcelona · Hospital Clinic de Barcelona, Barcelona · Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital Universitario La Paz, Madrid · Hospital Clínico San Carlos, Madrid · Hospital General Universitario Gregorio Marañón, Madrid · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario Virgen De La Macarena, Sevilla
Registry updated 2026-10-26
NCT05581121
PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer
Trial Treatment · Phase 3 · Institut Claudius Regaud
H.U. Vall d'Hebron, Barcelona · Hospital Clínic i Provincial de Barcelona, Barcelona · H. Josep Trueta, Girona · H.U. La Paz / Madrid, Madrid · H. Clínico San Carlos / Madrid, Madrid
Registry updated 2026-10-13
NCT06079671
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
Trial Treatment · Phase 3 · AstraZeneca
Complexo Hospitalario Universitario A Coruña, A Coruña · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Clinic de Barcelona, Barcelona · Hospital Universitario Reina Sofia, Córdoba · Institut Català d'Oncologia, Girona · Institut Catala D'oncologia, L'Hospitalet de Llobregat · Hospital Universitario Ramón y Cajal, Madrid · Hospital Universitario 12 de Octubre, Madrid · Hospital Clínico San Carlos, Madrid · Fundación Instituto Valenciano de Oncología, Valencia
Registry updated 2026-09-30
NCT05983432
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Trial Treatment · Phase 1 · SystImmune Inc.
Hospital de la Santa Creu i Sant Pau, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Beata María Ana, Madrid · START Madrid / Hospital Universitario Fundacion Jimenez Diaz, Madrid · Hospital Universitario 12 de Octubre, Madrid · START Madrid / Centro Integral Oncologico Clara Campal, Madrid · START Rioja, Piqueras · Hospital Universitario Virgen Macarena, Seville
Registry updated 2026-09-21
2025-521460-36-00
Prospective randomized study on sexual health and self-perceived quality of life (PROMs) in patients treated for cervical cancer
Trial Treatment · Phase 4 · Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer
Hospital Clinic de Barcelona, Barcelona · Hospital Vall d'Hebron, Barcelona · Hospital La Paz, Madrid · Hospital Universitario 12 de Octubre, Madrid · Hospital Clínico San Carlos, Madrid · Hospital Universitario de Navarra, Pamplona · Hospital Universitario Y Politecnico La Fe, Valencia
Registry updated 2026-08-20
NCT04895709
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Trial Treatment · Phase 1/2 · Bristol-Myers Squibb
Institut Catalan d Oncologia (ICO) - Badalona, Badalona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario Fundación Jiménez Díaz-START Madrid-FJD, Madrid · Hospital Universitario 12 de Octubre, Madrid · Centro Integral Oncologico Clara Campal-Hospital HM Universitario Sanchinarro-START Madrid-CIOCC, Madrid · Hospital Universitario Virgen de la Victoria, Málaga · Clinica Universidad de Navarra-oNCOLOGY, Pamplona
Registry updated 2026-08-17
NCT05592626
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Trial Treatment · Phase 1/2 · Marengo Therapeutics, Inc.
Vall d'Hebron Institute of Oncology, Barcelona · Hospital Universitario Quirónsalud Madrid, Madrid · START Madrid-FJD, Madrid · Instituto de Investigacion Sanitaria, INCLIVA, Valencia
Registry updated 2026-08-11
2023-506400-99-00
Phase II randomized study evaluating a Pragmatic approach to Adoptive Cell Therapy (ACT) using an IL2 analog (ANV419/ANV600) vs High dose IL2 after Tumor Infiltrating Lymphocytes (TIL) Therapy in patients with melanoma, NSCLC and cervical cancer. The PragmaTIL
Trial Treatment · Phase 2 · Vall D Hebron Institute Of Oncology
Hospital Universitari Vall d'Hebron, Barcelona
Registry updated 2026-07-23
NCT05768139
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Trial Treatment · Phase 1/2 · Eli Lilly and Company
Hospital HM Nou Delfos, Barcelona · Hospital Quirónsalud Barcelona, Barcelona · Hospital Universitari Dexeus Grupo Quironsalud, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital San Pedro, Logroño · Hospital Clínico San Carlos, Madrid · Hospital Universitario Fundación Jiménez Díaz, Madrid · MD Anderson Cancer Center, Madrid · Hospital Universitario HM Sanchinarro, Madrid · Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón · Salut Sant Joan de Reus, Reus · Hospital Universitario Virgen De La Macarena, Sevilla
Registry updated 2026-07-07
NCT04389632
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Trial Treatment · Phase 1 · Seagen, a wholly owned subsidiary of Pfizer
Hospital Quirónsalud Barcelona, Barcelona · Vall d'Hebron Institute of Oncology, Barcelona · Hospital HM Nou Delfos, Barcelona · Hospital General Universitario de Elche, Elche · Hospital de Jerez de la Frontera, Jerez de la Frontera · Hospital Universitario HM Sanchinarro, Madrid · Hospital Universitario Ramón y Cajal, Madrid · Hospital Universitario 12 de Octubre, Madrid · Hospital Quironsalud Malaga, Málaga · Hospital Universitario Marqués de Valdecilla, Santander
Registry updated 2026-07-06
NCT06024109
Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy
Research · Aesculap AG
Hospital Sant Joan de Déu de Manresa, Manresa
Registry updated 2026-06-02
NCT05642780
A basket study to investigate the efficacy and safety of SKB264 in combination with pembrolizumab in subjects with solid tumors
Trial Treatment · Phase 2 · Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd.
Hospital Universitari Dexeus Grupo Quironsalud, Barcelona · Hospital Clinic de Barcelona, Barcelona · Hospital del Mar, Barcelona · Hospital Universitari Vall d'Hebron, Barcelona · Hospital Universitario 12 de Octubre, Madrid · Complexo Hospitalario Universitario De Santiago, Santiago de Compostela · University Hospital Virgen Del Rocio S.L., Sevilla · Fundación Instituto Valenciano de Oncología, Valencia
Registry updated 2026-05-19
NCT05334706
A Study to Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women After Vaccination With 9vHPV (RIFT-HPV)
Trial Treatment · Phase 4 · Miquel Angel Pavon Ribas
Gynaecology Unit, Bellvitge University Hospital (HUB), L'Hospitalet de Llobregat
Registry updated 2026-02-23
NCT07412873
Study on Sexual Health and Self-perceived Quality of Life (PROMs) in Patients Treated for Cervical Cancer
Trial Treatment · Phase 4 · Fundacion Clinic per a la Recerca Biomédica
Laura Burunat, Teià
Registry updated 2026-02-17
NCT06630611
Evaluation of a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog (ANV419) vs High Dose IL2 After Tumor Infiltrating Lymphocytes (TIL) Therapy in Patients With Melanoma, NSCLC and Cervical Cancer (PragmaTIL)
Trial Treatment · Phase 2 · Vall d'Hebron Institute of Oncology
Vall d'Hebron Institute of Oncology, Barcelona
Registry updated 2025-01-28
NCT04989647
Intermediate Risk Cervical Cancer: Radical Surgery +/- Adjuvant Radiotherapy
Trial Treatment · Phase 3 · The Central and Eastern European Gynecologic Oncology Group
Hospital Clinic de Barcelona, Barcelona · Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca, Barcelona · Hospital Universitario Donostia, Donostia · Hospital Universitario Fundación Jiménez Díaz, Madrid · Hospital Universitario 12 de Octubre, Madrid · Hospital Universitario La Paz, Madrid · University Clinical Hospital Virgen De La Arrixaca, Murcia · Hospital Universitario Infanta Sofia, San Sebastián de los Reyes · Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife · Consorcio Hospital General Universitario de Valencia, Valencia · Hospital Universitario Y Politecnico La Fe, Valencia · Hospital Clinico Universitario Lozano Blesa, Zaragoza
Registry updated 2023-09-07

All Cervical cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error